Combination of cisplatin and interferon alfa-2a (Roferon-A) in patients with non small cell lung cancer (NSCLC). An open phase II multicentre study

By  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1028-1028

Elsevier

Access to resources Recommend Favorite

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

By                                  

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 465-470

Spandidos Publications

Access to resources Recommend Favorite

Activity of Gemcitabine in Patients with Non-small Cell Lung Cancer: A Multicentre, Extended Phase II Study

By Gatzemeier U.   Shepherd F.A.   Le Chevalier T.   Weynants P.   Cottier B.   Groen H.J.M.   Rosso R.   Mattson K.   Cortes-Funes H.   Tonato M.   Burkes R.L.   Gottfried M.   Voi M.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 243-248

Elsevier

Access to resources Recommend Favorite

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

By Kwon Jung   Kim Jung   Lee Jung-Ae   Shin Hyun   Kim Hyo   Song Hun   Jung Joo   Kim Ho   Choi Dae   Kim Hyeong   Park Young-iee   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 889-897

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J.   Monnier A.   Riviere A.   Milleron B.   Lemarie E.   Trillet-Lenoir V.   Soussan-Lazard K.   Berille J.   Douillard J.Y.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite